Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05849610
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-02-24
Brief Title:
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation